Life Sciences
-
Swedish EQT set to lead EU’s Scaleup Europe Fund
The EU has tasked EQT to head the new €5 billion ($5.8 billion) fund aimed at keeping Europe’s most promising tech companies from scaling abroad.
-
GRIP at PCC Canada 2026: Life sciences gain momentum, compliance evolves
GRIP will partner with Informa Connect’s Pharmaceutical Compliance Congress: Canada to capture how compliance leaders are helping the industry innovate responsibly amid regulatory complexity.
-
BMS partners with Anthropic to accelerate life sciences operations, research
The partnership will introduce Anthropic’s Claude’s agentic AI capabilities into research, clinical development, manufacturing, commercial operations, and corporate functions.
-
Health Canada announces task force to boost competitiveness in life sciences
Announcement comes as global pharmaceutical markets shift, with Canada facing pressure to secure investments and ensure timely access to new therapies.
-
Pharma congress tackles using AI in pharmaceutical compliance practice
At PCC 2026, pharma attendees heard that companies need to balance automation with human oversight while navigating evolving expectations around transparency, risk, and ethical implementation.
-
What the ECJ’s landmark ruling on defective products liability means for life sciences manufacturers
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
-
Changing UK product liability law: potential effects on the healthcare sector
Proactive steps companies in the healthcare sector (or those that insure or invest in those businesses) should take now.
-
UK Supreme Court delivers landmark ruling on AI patentability
The decision has significant implications for the patentability of computer-implemented inventions in UK sectors especially healthcare and life sciences.